Safety and Preliminary Diagnostic Performance of [⁶⁴Cu]Cu-RAX301 in Prostate Cancer

计划入组 52 人 · 首次发布于 2026 年 8 月 14 日

A Clinical Study to Evaluate the Safety, Pharmacokinetic Profile and Efficacy of CU-20401

计划入组 48 人 · 首次发布于 2022 年 1 月 19 日

A Phase I Clinical Trial Evaluating the Safety, Tolerability, and Pharmacokinetics of CU-40101 Liniment in Single and Multiple Doses in Adult Male Androgenic Alopecia Subjects

计划入组 62 人 · 首次发布于 2022 年 5 月 18 日

CU-06

CU-01

CU-20401

CU CHEMIE UETIKON GmbH

Germany

CU Anschutz Medical Campus

United States

CHULALONGKORN UNIVERSITY

Thailand

Great Southern Copper Reports High-Grade Cu-Ag Results from Mostaza Mine Drilling

Clarity Pharmaceuticals and SpectronRx Partner for Phase III Trial Manufacturing of Cu-64 SAR-bisPSMA

Element 29 Resources' Elida Project Shows Promising Drill Results and Outlines 2025 Exploration Plans